By Justin Leverenz, Chief Investment Officer, Developing Markets Equities China is unique among developing markets, not only ...

SPARC share price plunged 20% following poor Phase 2 trial outcomes for SCD-044. The stock peaked at ₹186 but fell to ₹156.50 ...

Sudhanshu Priyadarshi discusses scaling digital tools in finance, navigating trade volatility and balancing global leadership ...

As a member of Medicines for Europe, Polpharma Group joins industry leaders in calling on EU Prime Ministers to adopt a 5-Point Pharmaceutical Action Plan to protect patients, boost manufacturing, and ...

Does BioCryst Pharmaceuticals (BCRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Two units of the trading house will assist with everything from early-stage consulting, regulatory advice and clinical ...

Eight Philadelphia-area companies made this year’s Fortune 500 list, which ranks the country’s largest businesses by revenue.

Telomir-1 boosted telomere length, restored weight and muscle, and cut oxidative stress in a preclinical Werner Syndrome animal model.

As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes ...

Green chemistry isn’t always top of mind for industrial drug discovery chemists. This 4-point plan can get it there ...

Amneal Pharmaceuticals has recalled three lots of sulfamethoxazole and trimethoprim tablets that have black spots on their surface due to microbial contamination.

At about 3:10 pm, the Sensex was up 385.61 points or 0.48 percent at 81,383.86, and the Nifty was up 116.55 points or 0.47 ...